当前位置: 首页 SCI期刊 SCIE期刊 医学 中科院4区 JCRQ1 期刊介绍(非官网)
Nanomedicine

NanomedicineSCIE

国际简称:NANOMEDICINE-UK  参考译名:纳米医学

  • 中科院分区

    4区

  • CiteScore分区

    Q1

  • JCR分区

    Q1

基本信息:
ISSN:1743-5889
E-ISSN:1748-6963
是否OA:未开放
是否预警:否
TOP期刊:否
出版信息:
出版地区:ENGLAND
出版商:Future Medicine Ltd.
出版语言:English
出版周期:Monthly
出版年份:2006
研究方向:医学-纳米科技
评价信息:
影响因子:4.7
H-index:93
CiteScore指数:8.1
SJR指数:0.67
SNIP指数:0.562
发文数据:
Gold OA文章占比:8.87%
研究类文章占比:70.00%
年发文量:140
自引率:0.0363...
开源占比:0.1047
出版撤稿占比:0
出版国人文章占比:0.21
OA被引用占比:0.1158...
英文简介 期刊介绍 CiteScore数据 中科院SCI分区 JCR分区 发文数据 常见问题

英文简介Nanomedicine期刊介绍

Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond.

As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches.

Nanomedicine (ISSN 1743-5889) is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community.

The nanomedicine field is still in its infancy, however, in the next few years there are likely to be further exciting developments across medical science, engineering, chemistry and physics. Diverse researchers working together under the nanomedicine umbrella will produce findings with potential medical uses: preventing, diagnosing and treating human diseases, as well as relieving pain. Nanomedicine will provide a critical overview of these advances as they unfold, helping to shape the future of medicine in this exciting era.

期刊简介Nanomedicine期刊介绍

《Nanomedicine》自2006出版以来,是一本医学优秀杂志。致力于发表原创科学研究结果,并为医学各个领域的原创研究提供一个展示平台,以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述,从广泛的视角提供当前感兴趣的研究主题的新见解,或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

Cite Score数据(2024年最新版)Nanomedicine Cite Score数据

  • CiteScore:8.1
  • SJR:0.67
  • SNIP:0.562
学科类别 分区 排名 百分位
大类:Social Sciences 小类:Development Q1 26 / 306

91%

大类:Social Sciences 小类:Medicine (miscellaneous) Q1 51 / 398

87%

大类:Social Sciences 小类:General Materials Science Q1 99 / 463

78%

大类:Social Sciences 小类:Biomedical Engineering Q1 66 / 303

78%

大类:Social Sciences 小类:Bioengineering Q2 44 / 162

73%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Nanomedicine 中科院分区

中科院 2023年12月升级版 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
医学 4区 BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 NANOSCIENCE & NANOTECHNOLOGY 纳米科技 3区 4区

中科院分区表 是以客观数据为基础,运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据,得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次,类似于“优、良、及格”等。最开始,这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Nanomedicine JCR分区

2023-2024 年最新版
按JIF指标学科分区 收录子集 分区 排名 百分位
学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY SCIE Q1 29 / 174

83.6%

学科:NANOSCIENCE & NANOTECHNOLOGY SCIE Q2 55 / 140

61.1%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY SCIE Q2 82 / 174

53.16%

学科:NANOSCIENCE & NANOTECHNOLOGY SCIE Q2 64 / 140

54.64%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计
  • 国家/地区数量
  • CHINA MAINLAND178
  • USA120
  • India78
  • Italy43
  • England32
  • Spain31
  • Egypt29
  • Iran26
  • Australia24
  • Brazil23

本刊中国学者近年发表论文

  • 1、Smart nanostructures for targeted oxygen-producing photodynamic therapy of skin photoaging and potential mechanism

    Author: Wang, Yun; Lu, Zhaopeng; Huang, Yuqi; Jia, Wenyu; Wang, Wandong; Zhang, Xin; Chen, Cheng; Li, Yizhi; Yang, Chunsheng; Jiang, Guan

    Journal: NANOMEDICINE. 2023; Vol. 18, Issue 3, pp. 217-231. DOI: 10.2217/nnm-2022-0170

  • 2、Preparation and evaluation of paclitaxel-loaded reactive oxygen species and glutathione redox-responsive poly(lactic-co-glycolic acid) nanoparticles for controlled release in tumor cells

    Author: Wang, Siying; Han, Feng; Xie, Lanlan; Liu, Yanjie; Yang, Qilei; Zhao, Dongmei; Zhao, Xiuhua

    Journal: NANOMEDICINE. 2023; Vol. 17, Issue 22, pp. 1627-1648. DOI: 10.2217/nnm-2022-0164

  • 3、Nanomedicines in oral cancer: inspiration comes from extracellular vesicles and biomimetic nanoparticles

    Author: Bai, Yu-Ting; Zhang, Xue-Qiong; Chen, Xiao-Jie; Zhou, Gang

    Journal: NANOMEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.2217/nnm-2022-0142

  • 4、Nanoparticle vaccine based on the envelope protein domain III of Japanese encephalitis virus elicits robust protective immune responses in mice

    Author: Yao, Manman; Ren, Xujiao; Yin, Mengge; Chen, Huanchun; Li, Xiangmin; Qian, Ping

    Journal: NANOMEDICINE. 2023; Vol. 18, Issue 1, pp. 5-18. DOI: 10.2217/nnm-2022-0298

  • 5、Nanocarrier-based delivery of arsenic trioxide for hepatocellular carcinoma therapy

    Author: Sun, Jiang; Cheng, Mengying; Ye, Tingxian; Li, Bin; Wei, Yinghui; Zheng, Hangsheng; Zheng, Hongyue; Zhou, Meiqi; Piao, Ji-Gang; Li, Fanzhu

    Journal: NANOMEDICINE. 2023; Vol. 17, Issue 26, pp. 2037-2054. DOI: 10.2217/nnm-2022-0250

  • 6、Synergistic antitumor effect of folate-targeted Pluronic (TM) F-127/poly(lactic acid) polymersomes for codelivery of doxorubicin and paclitaxel

    Author: Wu, Tian Yi; Li, Zi Ling; Gong, Yan Chun; Xiong, Xiang Yuan

    Journal: NANOMEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.2217/nnm-2022-0212

  • 7、Polylactic-co-glycolic acid-based nanoparticles modified with peptides and other linkers cross the blood-brain barrier for targeted drug delivery

    Author: Na, Yue; Zhang, Ning; Zhong, Xinyu; Gu, Jinlian; Yan, Chang; Yin, Shun; Lei, Xia; Zhao, Jihui; Geng, Fang

    Journal: NANOMEDICINE. 2023; Vol. 18, Issue 2, pp. 125-143. DOI: 10.2217/nnm-2022-0287

  • 8、Cascade biomimetic intelligent nanotheranostic agents for imaging-guided tumor synergistic therapy

    Author: Fang, Zhengzou; Zhu, Ziyu; Zhuang, Zijian; Li, Zhangzuo; Yan, Cheng; Yang, Mengting; Chen, Qian; Li, Xinyuan; Gong, Aihua

    Journal: NANOMEDICINE. 2023; Vol. 18, Issue 1, pp. 35-52. DOI: 10.2217/nnm-2022-0266

投稿常见问题

通讯方式:FUTURE MEDICINE LTD, UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB。